CEL-SCI CORPORATION (CVM) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -22.70M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-22.70M | (m) |
| 2026-03-31 | (m) | $-22.70M | (m) |
| 2025-12-31 | (m) | $-23.81M | (m) |
| 2025-09-30 | (m) | $-25.41M | (m) |
| 2025-06-30 | (m) | $-26.08M | (m) |
| 2025-03-31 | (m) | $-27.27M | (m) |
| 2024-12-31 | (m) | $-27.94M | (m) |
| 2024-09-30 | (m) | $-27.58M | (m) |
| 2024-06-30 | (m) | $-28.44M | (m) |
| 2024-03-31 | (m) | $-29.95M | (m) |
| 2023-12-31 | (m) | $-31.05M | (m) |
| 2023-09-30 | (m) | $-32.19M | (m) |
| 2023-06-30 | (m) | $-33.03M | (m) |
| 2023-03-31 | (m) | $-34.29M | (m) |
| 2022-12-31 | (m) | $-35.77M | (m) |
| 2022-09-30 | (m) | $-36.70M | (m) |
| 2022-06-30 | (m) | $-36.44M | (m) |
| 2022-03-31 | (m) | $-35.75M | (m) |
| 2021-12-31 | (m) | $-37.21M | (m) |
| 2021-09-30 | (m) | $-36.36M | (m) |
| 2021-06-30 | (m) | $-33.54M | (m) |
| 2021-03-31 | (m) | (m) | (m) |
| 2020-12-31 | (m) | $-32.66M | (m) |
| 2020-09-30 | (m) | $-30.26M | (m) |
| 2020-06-30 | (m) | $-29.56M | (m) |
| 2020-03-31 | (m) | $-31.42M | (m) |
| 2019-12-31 | (m) | $-28.86M | (m) |
| 2019-09-30 | (m) | $-22.13M | (m) |
| 2019-06-30 | (m) | $-32.21M | (m) |
| 2019-03-31 | (m) | $-26.14M | (m) |
| 2018-12-31 | (m) | $-24.40M | (m) |
| 2018-09-30 | (m) | $-31.84M | (m) |
| 2018-06-30 | (m) | $-21.90M | (m) |
| 2018-03-31 | (m) | $-20.35M | (m) |
| 2017-12-31 | (m) | $-24.07M | (m) |
| 2017-09-30 | (m) | $-14.36M | (m) |
| 2017-06-30 | (m) | $-10.43M | (m) |
| 2017-03-31 | (m) | $-9.84M | (m) |
| 2016-12-31 | (m) | $-10.27M | (m) |
| 2016-09-30 | (m) | $-11.47M | (m) |
| 2016-06-30 | (m) | $-20.20M | (m) |
| 2016-03-31 | (m) | $-20.78M | (m) |
| 2015-12-31 | (m) | $-24.49M | (m) |
| 2015-09-30 | (m) | $-34.67M | (m) |
| 2015-06-30 | (m) | $-32.05M | (m) |
| 2015-03-31 | (m) | $-30.07M | (m) |
| 2014-12-31 | (m) | $-30.88M | (m) |
| 2014-09-30 | (m) | $-27.37M | (m) |
| 2014-06-30 | (m) | $-21.84M | (m) |
| 2014-03-31 | (m) | $-23.85M | (m) |
| 2013-12-31 | (m) | $-11.20M | (m) |
| 2013-09-30 | (m) | $-9.17M | (m) |
| 2013-06-30 | (m) | $-10.04M | (m) |
| 2013-03-31 | (m) | $-6.43M | (m) |
| 2012-12-31 | (m) | $-14.21M | (m) |
| 2012-09-30 | (m) | $-15.48M | (m) |
| 2012-06-30 | (m) | $-15.23M | (m) |
| 2012-03-31 | (m) | $-17.51M | (m) |
| 2011-12-31 | (m) | $-23.04M | (m) |
| 2011-09-30 | (m) | $-25.71M | (m) |
| 2011-06-30 | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) |
| 2010-09-30 | (m) | $10.48M | (m) |
| 2010-06-30 | (m) | (m) | (m) |
| 2009-09-30 | (m) | $-40.91M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |